A System to Help With Freezing of Gait in Parkinson's Patients

Condition(s) studied

Investigational drug(s) / intervention(s)

ParkinSense System: The noninvasive, body-worn ParkinSense system is intended help patients with Parkinson's prevent freezing of gait (FOG) and resume ambulation when FOG occurs. The system provides multiple modes of cueing, offers extensive cue personalization, and automatically detects FOG and issues one or more cues that have been tailored to an individual when FOG is detected.

Study summary

The goal of this clinical trial is to learn if the ParkinSense system, a customizable, multimodal, and adaptable cueing system, can assist with freezing of gait (FOG) in patients with Parkinson's disease. The main question it aims to answer is: is the percent of time spent frozen reduced when using the system compared to not using the system? Participants will be asked to take part in a single-visit laboratory study where they will wear the system in a controlled environment, followed by a two weeks of home use.

Eligibility

Primary outcome measure(s)

• Percent of time frozen — Day 1 (during the laboratory visit)
  The total duration of annotated FOG events for that sequence divided by the total duration of the sequence.

Trial sites (1)

More Barron Associates, Inc. trials in the USA